Sight Sciences (SGHT) Depreciation & Amortization (CF) (2020 - 2026)
Sight Sciences' (SGHT) quarterly Depreciation & Amortization (CF) came in at $103000.0 in Q1 2026, down 30.87% year-on-year from $149000.0 in Q1 2025, and down 4.63% quarter-over-quarter from $108000.0 in Q4 2025.
Sight Sciences (SGHT) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Sight Sciences' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $103000.0 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 30.87% year-over-year to $103000.0 in Q1 2026; TTM through Mar 2026 was $441000.0, a 34.08% decrease from a year earlier, with the FY2025 full-year figure at $487000.0, down 31.6% from the prior year.
- Depreciation & Amortization (CF) fell to $103000.0 in Q1 2026 per SGHT's latest filing, from $108000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $200000.0 in Q1 2022 and bottomed at $100000.0 in Q4 2022.
- The 5-year median for Depreciation & Amortization (CF) is $158000.0 (2024), against an average of $153882.4.
- Across the five-year window, Depreciation & Amortization (CF) jumped 100.0% in 2022 and slumped 38.64% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $100000.0 in 2022, then soared by 59.0% to $159000.0 in 2023, then gained by 10.69% to $176000.0 in 2024, then slumped by 38.64% to $108000.0 in 2025, then declined by 4.63% to $103000.0 in 2026.
- Per Business Quant, the three latest SGHT Depreciation & Amortization (CF) figures stand at $103000.0 (Q1 2026), $108000.0 (Q4 2025), and $105000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | 40.90 Mn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 67.10 Mn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Sight Sciences | 274.03 Mn | 189.07 Mn | 16.98 Mn | 103,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103,000.00 |
| Mar 31, 2026 | 103,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 176,000.00 |
| Dec 31, 2024 | 176,000.00 |
| Sep 30, 2024 | 158,000.00 |
| Sep 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 186,000.00 |
| Jun 30, 2024 | 186,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Dec 31, 2023 | 159,000.00 |
| Dec 31, 2023 | 159,000.00 |